Myeloperoxidase as an immunomodulator in intraoperative photodynamic therapy (Conference Presentation)

Richard W. Davis; Emma Snyder; Joann Miller; Astero Klampatsa; Steven Maceyko; Steven Albelda; Keith Cengel; Theresa M. Busch

doi:10.1117/12.2297115

14 March 2018 Myeloperoxidase as an immunomodulator in intraoperative photodynamic therapy (Conference Presentation)

Richard W. Davis, Emma Snyder, Joann Miller, Astero Klampatsa, Steven Maceyko, Steven Albelda, Keith Cengel, Theresa M. Busch

Author Affiliations +

Proceedings Volume 10476, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVII; 104760G (2018) https://doi.org/10.1117/12.2297115
Event: SPIE BiOS, 2018, San Francisco, California, United States

Abstract

Treatment of malignant pleural mesothelioma remains palliative in nature, and consists of surgical resection in order to achieve local control. More recently, surgical procedures which spare the lung (radical pleurectomy) have been coupled with photodynamic therapy (PDT) of residual disease to achieve better local control. Due to increasing evidence of the effects of surgery on both host immunity and residual tumor cells, we investigated the contribution of injuries sustained during surgery to efficacy of photodynamic therapy in a mouse model of malignant mesothelioma. We previously observed that surgical injury prior to PDT inhibits long-term response in vivo. As it relates to PDT outcome, we are now investigating neutrophil profiles in the presence and absence of surgical injury. Our results demonstrate that neutrophil influx into the tumor and lymph node occur sooner when PDT is preceded by surgical injury, as demonstrated by higher neutrophil counts in the respective tissue. Through in vivo imaging using luminol chemiluminescence as a marker of neutrophil activation, we show a role of neutrophil-secreted myeloperoxidase activity in producing long-term response after PDT. However, myeloperoxidase deposition in the lymph node is known to suppress dendritic cell migration, activation, and antigen uptake. Thus, we are currently investigating if early influx and activation of neutrophils in tumor draining lymph nodes results in a loss of establishment of PDT-mediated immunity. Taken together, these studies will describe potential immunomodulatory roles for myeloperoxidase in responses to intraoperative PDT.

Conference Presentation

Citation Download Citation

Richard W. Davis, Emma Snyder, Joann Miller, Astero Klampatsa, Steven Maceyko, Steven Albelda, Keith Cengel, and Theresa M. Busch "Myeloperoxidase as an immunomodulator in intraoperative photodynamic therapy (Conference Presentation)", Proc. SPIE 10476, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVII, 104760G (14 March 2018); https://doi.org/10.1117/12.2297115

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

Photodynamic therapy

Injuries

Lymphatic system

Tumors

In vivo imaging

Mesothelioma

Surgery

Show All Keywords

Keywords/Phrases

Search In:

Publication Years